[HTML][HTML] Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
…, JJ Boffa, M Ruivard, JP Ducroix… - … England Journal of …, 2008 - Mass Medical Soc
Background Current standard therapy for Wegener's granulomatosis and microscopic
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …
Is giant cell arteritis an infectious disease?: Biological and epidemiological evidence
P Duhaut, S Bosshard, JP Ducroix - La Presse Médicale, 2004 - Elsevier
… J Narvaez et al., in a retrospective study including mainly cases with pure PMR (85 PMR …
Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: …
Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: …
Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis.
R Delcenserie, T Yzet, JP Ducroix - Pancreas, 1996 - europepmc.org
Infectious complications currently account for 80% of deaths from acute pancreatitis. The aim
of this study was to evaluate the necessity for prophylactic antibiotics in patients with severe …
of this study was to evaluate the necessity for prophylactic antibiotics in patients with severe …
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients
…, J Cadranel, P Duhaut, G Choukroun, JP Ducroix… - Medicine, 2009 - journals.lww.com
We conducted the current study to investigate the clinical, laboratory, and histologic features
at presentation and the outcome of renal sarcoidosis (RS). Exhaustive retrospective data …
at presentation and the outcome of renal sarcoidosis (RS). Exhaustive retrospective data …
Thrombocytopenia in sarcoidosis.
…, JP Marolleau, P Duhaut, JP Ducroix - … vasculitis, and diffuse …, 2006 - europepmc.org
Background Haematological manifestations in sarcoidosis are uncommon. The prevalence
of thrombocytopenia in sarcoidosis is not well assessed. Aim
of thrombocytopenia in sarcoidosis is not well assessed. Aim
Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French …
…, M Ruel, E Vidal, M Piontud, JP Ducroix… - British journal of …, 1997 - academic.oup.com
Twenty-five patients with good-prognosis polyarteritis nodosa or Churg-Strauss syndrome
entered a prospective, randomized, multicentre study comparing two treatments: either oral …
entered a prospective, randomized, multicentre study comparing two treatments: either oral …
Long‐term outcomes among participants in the WEGENT trial of remission‐maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic …
…, O Chrétien, R Cevallos, JP Ducroix… - Arthritis & …, 2016 - Wiley Online Library
Objective Findings from the WEGENT trial and other short‐term studies have suggested that
azathioprine (AZA) or methotrexate (MTX) could effectively maintain remission of …
azathioprine (AZA) or methotrexate (MTX) could effectively maintain remission of …
Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis
…, JP Ducroix, V Cottin, J Haroche… - European …, 2013 - Eur Respiratory Soc
The aim of the present study was to investigate to what extent interstitial lung disease (ILD)
in common variable immunodeficiency disorder (CVID)-associated granulomatous disease (…
in common variable immunodeficiency disorder (CVID)-associated granulomatous disease (…
Paecilomyces variotii fungemia in a patient with multiple myeloma: case report and literature review
…, A Smail, A Vaidie, C Dayen, JL Schmit, JP Ducroix… - Journal of Infection, 2005 - Elsevier
Infectious complications are common in patient with multiple myeloma. However, Paecilomyces
variotii, a common saprophytic fungus, rarely causes human infection. We report the first …
variotii, a common saprophytic fungus, rarely causes human infection. We report the first …
Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss
…, H Pellet, JC Piette, H Sevestre, JP Ducroix - Annals of the …, 2009 - ard.bmj.com
Background: Permanent visual loss (PVL) is the most feared complication of giant cell arteritis
(GCA), and its risk factors are still unclear. Objectives: The aim of our study was to assess …
(GCA), and its risk factors are still unclear. Objectives: The aim of our study was to assess …